Complicating Changes: Medical Microbiologist Comments on the Mutating Ebola Virus
Saint Joseph's University
Researchers develop first genetic strain of mice that can be infected with Ebola and display symptoms similar to those that humans experience. This work will significantly improve basic research on Ebola treatments and vaccines.
Johns Hopkins Nursing responds to forced quarantine and eventual release of graduate Kaci Hickox.
Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded $2 million by the U.S. Department of Defense (DoD) to aid in the development and manufacturing of a vaccine to protect against infection by filoviruses, including the Ebola and Marburg viruses.
Two, free online Ebola education downloadable courses will provide easy-to-understand instruction and resources for health care professionals, as well as the general public.
Johns Hopkins Medicine has been tasked by the Centers for Disease Control and Prevention to lead a group and to design an interactive Web-based learning program that guides health care workers, nurses and physicians through government-approved protocols to aid clinicians as they provide care to patients who may be at risk of contracting the Ebola virus. The program trains health care providers in three critical areas: proper donning of personal protective equipment (PPE), the safe removal of gear and active monitoring skills. All three modules will be available for free on the CDC’s website in the coming weeks and later available to the millions of iOS users on iTunes U.
IU McKinney School of Law, on the Indiana University-Purdue University Indianapolis campus, will host a public forum on Ebola, law and public health today. The lecture will be available live and archived online.
A new study is helping to rewrite Ebola’s family history. It shows that Ebola and Marburg are each members of ancient evolutionary lines, and that these two viruses last shared a common ancestor sometime prior to 16-23 million years ago.
It dominates the headlines and is striking fear and panic in many communities around the world, Ebola. The constant barrage of information and so much unknown can be especially difficult for children, making it all the more important for parents to help their kids feel safe and to have a dialogue with them at the appropriate developmental level.
Researchers at the U.S. Army Natick Soldier Research, Development and Engineering Center in Natick, Mass., invented a novel and potent disinfectant system that kills the Ebola virus on surfaces. The center transferred the process to a private company, which is manufacturing the portable “no power required” chemical compound and supplying it worldwide, including the front lines of West Africa.
The American Association of Critical-Care Nurses, the American Organization of Nurse Executives and the Emergency Nurses Association have issued a joint statement about specialty nursing and leadership organization collaboration related to Ebola Virus Disease, on behalf of their 150,000-plus combined nurse members.
Study highlights need to monitor disease in developing countries even when burden of diseases is low.
For many months, the world has witnessed the Ebola virus spread and claim more than 4,400 lives in West African countries. On Oct. 8, the first confirmed adult Ebola patient identified in the United States died. The constant news coverage has heightened concern among parents who fear their children will become infected.
As medical personnel and public health officials are responding to the first reported cases of Ebola Virus in the United States, many of the safety and treatment procedures for treating the virus and preventing its spread are being reexamined. One of the tenets for minimizing the risk of spreading the disease has been a 21-day quarantine period for individuals who might have been exposed to the virus. But a new study by Charles Haas, PhD, a professor in Drexel’s College of Engineering, suggests that 21 days might not be enough to completely prevent spread of the virus.
With the 2014-15 flu season officially underway, pharmacy professor Daniel Hussar, PhD, at Philadelphia College of Pharmacy at University of the Sciences, urges people to stop worrying about Ebola and get a flu shot instead.
Case Western Reserve University will present Ebola expert, Daniel Bausch, MD, in a public special lecture from 2 to 3 p.m., Thursday, Oct. 16, in Wolstein Research Building Auditorium, 2103 Cornell Rd., Cleveland. He will address “From the Front Lines of the Battle with Ebola.”
A patient being treated at a Dallas hospital is the first person to be diagnosed with Ebola in the United States, health officials announced yesterday. According to the Centers for Disease Control and Prevention (CDC), the unidentified man left Liberia on September 19 and arrived in the United States on September 20. At that time, the individual did not have symptoms, but several days later, he began to feel ill. He went to a local emergency department, but was discharged and went home. As he continued to be symptomatic, he went to the emergency department of Texas Health Presbyterian Hospital where is was admitted and isolated on Sunday.
Born in Sierra Leone, Mafudia Suaray, a family physician at Rutgers Robert Wood Johnson Medical School, is helping to raise awareness about the disease. She answers some of the common questions about this new international health crisis.
Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.
A statistical report from the Centers of Disease Control and Prevention aligns with a previously released estimate about the potential threat of the Ebola virus by a national group of scientists, including simulation scientists with Virginia Tech.
Thomas Jefferson University’s Ebola vaccine is one of the front runners of those currently in development.
A team of American infectious disease and critical care experts is alerting colleagues caring for Ebola patients that how they remove their personal protective gear can be just as crucial as wearing it to prevent exposure to the deadly virus.
To learn more about this outbreak and the creation of new human vaccines, Vermont Medicine, a publication of the University of Vermont College of Medicine, talked to infectious disease experts Beth Kirkpatrick, M.D., UVM Vaccine Testing Center director, and Kristen Pierce, M.D., who have led vaccine studies for such global pathogens as cholera, West Nile virus, dengue, typhoid fever and anthrax.